Merck & Co., Inc. (MRK)
NYSE
$147.73
+$0.85
(+0.58%)
Previous Close: $146.95
Market Closed
Merck & Co., Inc. (MRK) Live Price Chart
Last updated: 2026-11-14 11:49:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Merck & Co., Inc. (MRK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $147.73, with a market capitalization of $362.27B and a P/E ratio of 147.68. Over the past 52 weeks, its price has ranged from $91.49 to $156.92. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$362.27B | |
$147.31 | |
$147.97 | |
$145.26 | |
$146.95 | |
4.40M | |
10.29M | |
147.68 | |
$156.92 | |
$91.49 | |
2.31% | |
-- |
Merck & Co., Inc. (MRK) Latest Closing Stock Price
Merck & Co., Inc. (MRK) last closed at $147.73 as of 2026-11-14 01:00:00, up 0.58% ($0.85) from the previous close of $146.95.
During the latest regular trading session, MRK traded between $145.26 and $147.97, with a volume of 4.40M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Merck & Co., Inc. (MRK) 7-Day Stock Price Change
Over the past seven days, Merck & Co., Inc. (MRK) moved from $146.94 to $147.73, representing a gain of 0.53% ($0.79).
The stock traded between $142.80 and $153.37 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 7.33 million shares, down versus the previous seven-day period, indicating lower trading activity.
MRK 52-Week Price Position
Position in Range: 85.9%
52W Low$91.49
52W High$156.92
MRK is currently trading at $147.73, placing it 85.9% of the way from its 52-week low of $91.49 to its 52-week high of $156.92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Merck & Co., Inc. (MRK)?
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Merck & Co., Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 75,000 |
| Exchange | NYSE |
| Company Website |
MRK Stock Events
View the latest dividend and stock split events for Merck & Co., Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Sep 15, 2026 |
| Payment Date | Oct 7, 2026 |
| Dividend Per Share | $0.85 |
MRK News
Latest news related to Merck & Co., Inc. and MRK stock.
- BenzingaRead Full Article
- BenzingaRead Full Article
Merck Says FDA Set March 22, 2027 PDUFA Date For Enflonsia Second-Season sBLA
- BenzingaRead Full Article
Merck Says EMA’s CHMP Recommends Approval Of Expanded Enflonsia Indication To Prevent RSV In At-Risk Children Up To 24 Months Through Second RSV Season; EC Decision Expected Within Two Months
- BenzingaRead Full Article
FDA Reportedly Shelves Fast-Track Drug Review Pilot Program During Leadership Vacuum: Report
The FDA reportedly shelves its fast-track drug voucher pilot amid internal chaos, returning review oversight to career scientists.
- MassiveRead Full Article
MRNA Stock Up 3% Since Q3 Earnings Release: How to Play the Stock?
Moderna shares gained 3% following better-than-expected Q3 2026 earnings and raised full-year revenue guidance to 15-25% growth, driven by stronger international COVID-19 vaccine sales. The company's oncology pipeline, particularly its personalized cancer therapy intismeran developed with Merck, showed promising phase III results with a 42% reduction in recurrence or death risk. Despite premium valuation and ongoing cash burn concerns, Moderna maintains a Zacks Rank #2 (Buy) rating, supported by expanding respiratory vaccine portfolio and oncology opportunities.
Ways to Trade MRK at MEXC
How to Buy Merck & Co., Inc. (MRK) Stock on MEXC
Eligible investors can buy real shares of Merck & Co., Inc. (MRK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for MRK and Place Your Order
Open the RealStocks trading page and search for MRK. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.
Frequently Asked Questions (FAQ)
1.What is Merck & Co., Inc. (MRK) stock price today?
Merck & Co., Inc. (MRK) is currently trading at $147.73, up 0.58% ($0.85) from the previous close of $146.95. Intraday prices update in real time during regular trading hours.
2.Is MRK stock going up or down today?
As of 2026-11-14 01:00:00, MRK is trading at $147.73, up 0.58% ($0.85) from its previous close of $146.95. The stock has traded between $145.26 and $147.97 during today’s regular session. Past price movements do not guarantee future results.
3.What is MRK pre-market price?
As of 2026-11-14 01:00:00, MRK is trading at $147.50 in pre-market trading, up 0.38% ($0.55) from the previous close of $146.95. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is MRK after-hours price?
As of 2026-11-14 01:00:00, MRK is trading at $147.75 in after-hours trading, up 0.02% ($0.02) from the regular-session close of $147.73. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is MRK stock trading now?
MRK trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does MRK sit relative to its 52-week high and low?
Over the past 52 weeks, MRK has traded between a low of $91.49 and a high of $156.92. At $147.73, the stock is positioned 85.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Merck & Co., Inc. in?
Merck & Co., Inc. (MRK) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Merck & Co., Inc.'s market capitalization and where is it listed?
Merck & Co., Inc. is listed on the NYSE exchange with a market capitalization of $362.27B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is MRK valued in terms of P/E ratio and EPS?
MRK trades at a P/E ratio of 147.68, based on trailing-twelve-month EPS of $1.00. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Merck & Co., Inc. pay a dividend?
Merck & Co., Inc. pays an indicated annual cash dividend of $3.41 per share, with a current dividend yield of 2.31% based on the latest share price. Dividend policies are subject to change at the board's discretion.
Explore More US Stocks
Stocks in the Same Sector
Browse other US stocks in the same sector as Merck & Co., Inc.
Largest Market Cap
See US stocks with the highest market capitalization
Most Actively Traded
Discover today's most actively traded US stocks
Top Gainers
Browse today's leading gainers in the US stock market
Top 5 Cryptocurrencies
Explore the cryptocurrencies with the highest market capitalization
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MRK, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
MRK Stock Calculator
Estimate the value between MRK shares and USD.
MRK Shares to USD
MRK Shares
MRK
USD
USD
1.00 MRK shares = 147.726 USD
Calculations are estimates based on the latest available price and are for reference only.